ReviewFrontiers in immunology2024

Metabolism-driven glycosylation represents therapeutic opportunities in interstitial lung diseases.

Katarzyna Drzewicka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.